Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, Large B-Cell, Diffuse

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

NCT00003538

Conditions: Adnexal Diseases, Anemia, Blast Crisis, +110 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

NCT00003572

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +46 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Completed

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00003962

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +50 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Completed

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

NCT01231919

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, +130 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Childrens Hospital of Orange County Orange, California, United States

University of California San Francisco Medical Center-Parnassus San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

View all 25 locations

View Trial Details

Completed

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00265837

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma

NCT00724984

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +24 more
Locations: University of California, San Francisco San Francisco, California, United States

Northwestern University Medical School Chicago, Illinois, United States

Horizon Oncology Center Lafayette, Indiana, United States

University of Massachusetts Medical School Worcester, Massachusetts, United States

View Trial Details

Completed

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

NCT01233921

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

NCT00890747

Conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
Locations: Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States

Northwestern University Chicago, Illinois, United States

AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States

View Trial Details

Completed

Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004145

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +52 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat

NCT00791011

Conditions: Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations: Not specified

View Trial Details